Skip to main content
  • Home
  •  Transcatheter Interventions Online - Complete Higher Risk Indicated Percutaneous Coronary Intervention: Focus on CTO

Transcatheter Interventions Online - Complete Higher Risk Indicated Percutaneous Coronary Intervention: Focus on CTO

Topic:
  • Intervention
  • MI/ACS

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

TIO 2020 – Focus on CTO

Overview

In this session, part of the Transcatheter Interventions Online 2020 programme, an international faculty provide comprehensive update on the latest in indications and classifications, and antegrade and retrograde techniques in CTO.

 

Transcatheter Interventions Online (TIO) aims to educate interventionalists and allied healthcare professionals on the practical implications of the latest clinical data, device selection, and procedural strategies impacting optimum patient care. To further illustrate this, the event will feature a number of practical demonstrations in the form of live cases broadcast from cardiovascular centers of excellence globally, interspersed with presentations and debate sessions.

Support Statement

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.

  • Abbott
  • Abiomed
  • Boston Scientific
  • Edwards Lifesciences
  • Medtronic
  • Siemens Healthineers

Disclosure

In compliance with EBAC / EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

    Terms & Conditions

    Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

     

    The session ‘Transcatheter Interventions Online - Complete Higher Risk Indicated Percutaneous Coronary Intervention: Focus on CTO’ is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credits.

     

    Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

     

    Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

    Instructions to Participants

    There is no fee for taking part in this online learning activity.

     

    Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

     

    To complete the course and claim certification participants must:

    • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
    • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

    Target Audience

    • Cardiologists, interventionalists and surgeons who are involved and/or interested in transcatheter treatment strategies for coronary and structural heart disease.

    Learning Objectives

    Upon completion of this activity, participants will be able to:

    • Evaluate emerging clinical data related to interventional cardiology practice including for both devices and pharmacology
    • Recognise the latest interventional approaches for SHD and Complex PCI available for the optimal management of CV patients
    • Assess the merits of adopting emerging technologies within their practice
    • Apply the practical guidance to maximise success of their interventional procedures within TAVR, Mitral & Tricuspid Valve Replacement and Complex PCIs
    • Interact with opinion leaders in their profession

    Module

    Title

    Duration

    Speakers

    1 Indications and classifications Holger Thiele (Heart Center Leipzig, Germany)
    2 Essentials on antegrade techniques Didier Tchétché (Clinic Pasteur, France)
    3 Essentials on retrograde techniques Margaret B McEntegart (Golden Jubilee National Hospital, Glasgow)
    1.

    Indications and classifications

    Duration:

    Speakers: Holger Thiele (Heart Center Leipzig, Germany)

    2.

    Essentials on antegrade techniques

    Duration:

    Speakers: Didier Tchétché (Clinic Pasteur, France)

    3.

    Essentials on retrograde techniques

    Duration:

    Speakers: Margaret B McEntegart (Golden Jubilee National Hospital, Glasgow)

    Chair

    Ajay J Kirtane

    Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, US

    Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr.

    View full profile

    Nicolas M Van Mieghem

    Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL

    Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others.

    View full profile

    Panelist

    Holger Thiele

    Leipzig Heart Center, Leipzig, DE

    Dr Holger Thiele, former director and full professor in the Department of Internal Medicine/Cardiology/Angiology of the University Heart Center Lübeck at the University of Lübeck has been nominated by the faculty of the University of Leipzig as full Professor and Director of the Department of Int

    View full profile

    Didier Tchétché

    Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France

    Didier Tchétché, (Clinique Pasteur, Toulouse, France) Graduated from the University of Paris V where Dr Tchétché obtained his post-graduate diploma of cardiovascular pathology in 2004.

    View full profile

    Margaret B McEntegart

    West of Scotland Regional Heart and Lung Centre in Glasgow

    Dr McEntegart is a Consultant Interventional Cardiologist at Golden Jubilee National Hospital and Honorary Associate Clinical Professor of the University of Glasgow, and clinical lead for the complex PCI and CTO programmes.

    View full profile

    Azeem Latib

    Montefiore Medical Center, New York, NY, US

    Dr Mohamed Azeem Latib is a world-leading expert in Interventional Cardiology. Dr Latib is the Section Head and Director of Interventional Cardiology as well as the Director of Structural Heart Interventions at the Montefiore-Einstein Center for Heart and Vascular Care. 

    View full profile
    1.00 EBAC

    1.00 EBAC

    Related Courses

    TIO 2023 – Symposium: Lifetime Patient Management Greater Expectations: Is TAVI Rising to The Challenge?
    • 1.00 EBAC

    Learning objectives

    • Recall the latest data on durability and clinical outcomes for TAVI
    • Understand how TAVI is advancing and become aware of future treatment options for lifetime management of patients with aortic valve disease
    • Become more confident using TAVI in cases with complex anatomy
    See more
    Individualising Antithrombotic Strategies for Established CAD
    • 1.00 EBAC

    Learning objectives

    • Summarise current guidance for choosing antithrombotic therapy in established CAD
    • Describe current gaps in clinical evidence and what is missing from current guidance
    • Adopt an evidence-based approach for managing patients with ACS and CCS
    See more
    Transcatheter Edge-to-Edge Repair: An Assessment of its Long-term Impact on Mitral Regurgitation
    • 1.00 EBAC

    Learning objectives

    • Recall the long-term outcomes of TEER from real-world and RCT data
    • Apply the results of real-world data to both simple and complex patients
    • Describe how TEER is being used to benefit a range of patients with MR
    See more
    Severe Aortic Stenosis: Stratifying Patients for Lifetime Management
    • 1.00 EBAC

    Learning objectives

    • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
    • Summarise clinical evidence for TAVI in low surgical risk patients
    • Recall different guideline recommendations for SAVR and TAVI approaches
    • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient
    See more
    Renal Denervation In The Real World: Practical Guidance For New Users
    • 1.00 EBAC

    Learning objectives

    • Assess the current global burden of resistant hypertension
    • Carry out appropriate assessments to identify resistant hypertension
    • Identify patients most likely to benefit from RDN
    • Recall the practical considerations for adopting RDN into routine practice
    • Recall the latest data on RDN from recent clinical trials
    See more
    Getting it Right First Time in Severe Aortic Stenosis - Key insights for Long Term Success
    • 1.00 EBAC

    Learning objectives

    • Recall current and predicted trends in TAVI with respect to preserving coronary access
    • Consider determining factors for choosing valves in low risk populations
    • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
    See more
    Optimising Outcomes For The TAVI Patient: Key Considerations For First Valve Choice And Implantation Techniques
    • Not accredited

    Learning objectives

    • Recall the latest data showing why durability and hemodynamics matter for initial valve selection
    • Discuss the latest techniques to help achieve optimal outcomes for patients with longer life expectancy
    • Review TAVI cases that highlight procedure optimisation with the Evolut pro+ platform
    See more
    TIO 2022 - Session 3.4: Debates
    • 1.00 EBAC

    Learning objectives

    • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
    • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
    • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
    • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
    • Discuss the need for gender-specific trials and renal denervation
    See more
    TIO 2022 - Session 3.3: Keynote & Controversies: Live Cases And Discussion
    • 1.00 EBAC

    Learning objectives

    • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
    • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
    • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
    • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
    • Discuss the need for gender-specific trials and renal denervation
    See more
    TIO 2022 - Session 3.1 & 3.2: Keynote & Controversies
    • 1.00 EBAC

    Learning objectives

    • Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
    • Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
    • Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
    • Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
    • Discuss the need for gender-specific trials and renal denervation
    See more